Critical care is a direct delivery of medical care by physicians for critically ill or injured patient. Critical care diagnostics involve intensive care of patients dealing with serious conditions that require sophisticated invasive or non-invasive monitoring devices alongside other life support systems. It is also known as point of care, which is used for diagnosis of life threatening diseases occurring in patients. It includes cardiac markers diagnostics, cancer biomarker test, blood glucose testing, blood gas & electrolyte analysis, pregnancy testing, drugs of abuse, urine stripe testing, cholesterol screening, food pathogens screening, haemoglobin diagnostics and infectious disease testing. It is cost effective and provides appropriate & rapid diagnosis.
According to study, “Global Critical Care diagnostics Market Size study, by Type (Flow cytometry, Immunoproteins, Routine and special chemistry, Hematology, Coagulation test, Microbial and infectious diseases and others) End-user (Intensive care units, Emergency rooms, Operating rooms and others) and Regional Forecasts 2018-2025” key companies operating in the global critical care diagnostics market are Becton Dickinson and Company, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Bio-Rad Laboratories, Alere, Inc., Siemens Healthineers, Beckman Coulter, Inc., Nova Biomedical, Bayer AG, BioMerieux, Inc.
Based on product type, market is segmented into cancer markers testing kit, coagulation monitoring kits, cardiometabolic monitoring kits, pregnancy & fertility testing kits, glucose monitoring kits, fecal occult testing kits, hematology testing kits, drugs-of-abuse testing kits, infectious disease testing kits, cholesterol test strips and other critical care diagnostics testing kits. Based on test type, critical care diagnostics market is segmented into low cytometry, routine & special chemistry, immunoproteins, hematology, microbial & infectious diseases, coagulation test and others. The immunoproteins diagnostic test segment dominates the market with largest share owing to rise in demand for accurate preventive healthcare services. In addition, based on end-user, market is segmented into intensive care units, operating room, emergency rooms, and others. The emergency room segment is predictable to witness lucrative growth as it offers initial acute care treatment & diagnosis to critically ill patients during the forecast period.
The critical care diagnostics market is driven by rise in prevalence of chronic diseases & lifestyle-related disorders, followed by rapid awareness and acknowledgment of the tests by physicians & patients, quick & accurate test results to diagnose the disease, growth in adoption of telehealth services & remote communications, increase in demand for early diagnosis & treatment, improvement in the reimbursement scenario and rise in data management & connectivity through interoperability to Electronic Health Record (EHR). However, lack of skilled professionals and high cost of molecular diagnostics tools may impact the market. Moreover, growth in advancement in technologies is a key opportunity for market.
Based on geography, the North-American region holds the leading position in critical care diagnostics market, followed by European region, owing to presence of well-established healthcare infrastructure and rise in research & development (R&D) activities in the region. The Asian-Pacific region is estimated to witness higher growth rate due to rise in geriatric population and high prevalence of chronic diseases over the forecast period. In upcoming years, it is expected that future of the market will be bright caused by growth in development of medical organizations and rise in government initiatives in implementing critical care diagnostics during the forecast period. It is anticipated that the global market will be reached at US $1.4 billion, by 2025.
For more information on the research report, refer to below link:-
Ankur Gupta, Head Marketing & Communications